Pharmaceutical Granulation Equipment Market: Size, Trends, Growth & Forecast 2025–2032

The Global Pharmaceutical Granulation Equipment Market is projected to experience steady growth over the coming years, driven by increasing pharmaceutical production, technological advancements, and stringent regulatory requirements. According to industry analysis, the market is expected to grow at a CAGR of approximately 6.1%, reaching nearly USD 7,828.2 million by 2032 from an estimated USD 5,124.3 million in 2025.

Pharmaceutical granulation equipment plays a vital role in the production of solid dosage forms such as tablets and capsules. The granulation process improves powder properties, ensuring uniformity, better flowability, compressibility, and enhanced drug bioavailability.

What is Pharmaceutical Granulation Equipment?

Pharmaceutical granulation equipment refers to specialized machinery used to convert fine powders into granules. This process is essential for ensuring consistent drug formulation and efficient manufacturing. Granulation:

• Enhances powder flow and compressibility
• Reduces dust formation and segregation
• Ensures uniform distribution of active pharmaceutical ingredients (APIs)
• Improves product stability and quality

As pharmaceutical formulations become more complex, advanced granulation technologies are becoming increasingly important.

Free Request Sample: https://www.metastatinsight.com/report/pharmaceutical-granulation-equipment-market#

Key Market Growth Drivers

1. Growing Pharmaceutical Production

The increasing global demand for medications, fueled by rising chronic diseases and an aging population, is driving the need for advanced manufacturing equipment.

2. Stringent Regulatory Standards

Regulatory authorities require strict compliance with quality and safety standards. This pushes manufacturers to adopt modern granulation systems with enhanced precision and monitoring capabilities.

3. Technological Advancements

Integration of automation, real-time monitoring, and smart manufacturing technologies has significantly improved the efficiency and consistency of granulation processes.

4. Demand for Controlled and Personalized Medicine

The rising development of controlled-release formulations and personalized drugs is increasing demand for flexible and scalable granulation equipment.

Market Segmentation

By Type

• Single Pot Granulators
• High Shear Granulators
• Oscillating Granulators
• Other Specialized Systems

High shear granulators are widely used for producing uniform granules in high-volume production environments.

By Mechanism

• Wet Granulators
• Dry Granulators
• Mixture Granulators

Wet granulation remains a dominant technique due to its ability to enhance powder cohesion and uniformity.

By End User

• Pharmaceutical Manufacturing Companies
• Contract Manufacturing Organizations (CMOs)
• Biotech Firms
• Academic and Research Institutions

Pharmaceutical manufacturers represent the largest share, while CMOs are experiencing rapid growth due to outsourcing trends.

Regional Insights

North America

North America holds a significant market share due to advanced pharmaceutical infrastructure and strong research and development investments.

Europe

Europe continues to grow steadily, supported by strict regulatory frameworks and innovation-driven pharmaceutical companies.

Asia-Pacific

Asia-Pacific is expected to witness the fastest growth, driven by expanding pharmaceutical manufacturing hubs in countries such as India, China, and Japan.

South America & Middle East and Africa

These regions are gradually expanding due to increasing healthcare investments and improving pharmaceutical production capabilities.

Competitive Landscape

Key companies operating in the Pharmaceutical Granulation Equipment Market focus on innovation, automation, and energy-efficient systems. Major industry participants include:

• GEA Group
• Glatt GmbH
• Hosokawa Micron Powder Systems
• IMA Group
• Freund-Vector Corporation
• Kevin Process Technologies
• Romaco Group
• Syntegon Technology GmbH
• ACG Group
• Fitzpatrick Company
• O'Hara Technologies Inc.

These companies are investing in advanced technologies and strategic collaborations to strengthen their global presence.

Source: https://www.metastatinsight.com/report/pharmaceutical-granulation-equipment-market

Future Outlook

The Pharmaceutical Granulation Equipment Market is expected to maintain steady expansion through 2032, supported by:

• Adoption of Industry 4.0 technologies
• Increasing focus on sustainable manufacturing
• Growing demand for solid oral dosage forms
• Expansion of contract manufacturing services

With rising healthcare needs and ongoing pharmaceutical innovation, granulation equipment will remain a critical component of efficient drug production systems worldwide.